ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Systemic JIA and drug therapy"

  • Abstract Number: 2693 • ACR/ARP Annual Meeting 2019

    Increasing Use of Biologics over Time in the First Year After Diagnosis of Systemic JIA Among Patients Enrolled in the Childhood Arthritis & Rheumatology Research Alliance (CARRA) Registry

    Ginger Janow1, Timothy Beukelman 2, Yukiko Kimura 3, Rayfel Schneider 4, Shalini Mohan 5, Gail Rodich 6 and Mary Beth Son 7, 1Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, NJ, 2University of Alabama Birmingham, Birmingham, AL, 3Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Cincinnati, OH, 4Hospital for Sick Children, Toronto, ON, Canada, 5Genentech, Inc., South San Francisco, CA, 6Genentech, San Francisco, 7Boston Children's Hospital, Boston, MA

    Background/Purpose: Prior to the development of anti-cytokine therapies, treatment for systemic juvenile idiopathic arthritis (SJIA) included high dose glucocorticoids and non-biologic disease modifying anti-rheumatic drugs…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology